Topic Highlight
Copyright ©The Author(s) 2016.
World J Gastroenterol. Jun 21, 2016; 22(23): 5332-5341
Published online Jun 21, 2016. doi: 10.3748/wjg.v22.i23.5332
Table 1 Cetuximab combined with cytotoxic chemotherapeutic regimens for the first-line treatment of advanced colorectal cancer
Name of studyClinical trial phasenChemotherapyOS (mo)PFS (mo)
FIRE-3[55-57]3171Cmab + FOLFIRI33.110.2
CALGB80405[12]3547Cmab + CT29.9310.5
COIN[58]3279Cmab + FOLFOX14.98.5
COIN3523Cmab + CAPOX15.07.4
Souglakos et al[59]2167Cmab + FOLFIRI25.710.0
Souglakos et al[59]2166Cmab + CAPIRI27.58.9
CELIM[60,61]356Cmab + FOLFOX635.711.2
CELIM355Cmab + FOLFIRI29.010.5
CECOG/CORE1.2.001[62]274Cmab + FOLFOX617.48.6
CECOG/CORE1.2.001277Cmab + FOLFIRI18.98.3
CRYSTAL[63,64]3316 (WT)Cmab + FOLFIRI23.59.9
Nordic VII[65]397 (WT)Cmab + Nordic FLOX(bolus)20.17.9
COIN[66]3362 (WT)Cmab + CAPOX/FOLFOX17.08.6
Borner[67]237Cmab + CAPOX20.57.2
OPUS[68,69]282 (WT)Cmab + FOLFOX418.37.2